サマリー

吸収不良症候群の世界市場 2022-2026 年
Technavioは吸収不良症候群市場を監視しており、2022-2026年の間に15億5000万ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、吸収不良症候群市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、グルテンを含む食品の消費量の増加、乳糖不耐症の有病率の増加、政府の取り組みや啓蒙活動などによって牽引されています。
吸収不良症候群の市場分析には、疾患タイプ別セグメントと地理的展望が含まれます。
Technavioの吸収不良症候群市場は、以下のようにセグメント化されています。
疾患タイプ別
- 乳糖不耐症
- スプルー
- 嚢胞性線維症
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、欧州、北米、南米における嚢胞性線維症の有病率の増加が、今後数年間における吸収不良症候群市場の成長を促進する主要な理由の1つであると特定しています。また、無機的な成長戦略や、注目される市場における医薬品メーカーの強固なパイプラインは、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。吸収不良症候群市場に関する当レポートの対象領域は次のとおりです。
- 吸収性症候群の市場サイジング
- 吸収性症候群の市場予測
- 吸収不良症候群市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Ache Laboratorios Farmaceuticos SA、Aspen Pharmacare Holdings Ltd.、Bausch Health Companies Inc、Baxter International Inc、COSMO PHARMACEUTICALS NV、Fering B.V., Koninklijke DSM NV、Lannett Co. Inc.、Merck and Co.Inc.、Novartis AG、Organon and Co.、Perrigo Co.Plc、ProThera Biologics Inc.、Sanofi、Tillotts Pharma AG、Xspire Pharma LLC、Pfizer Inc.などです。また、吸収不良症候群の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/malabsorption-syndrome-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Lactose intolerance - Market size and forecast 2021-2026
o Exhibit 28: Chart on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Lactose intolerance - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Lactose intolerance - Year-over-year growth 2021-2026 (%)
o 5.4 Sprue - Market size and forecast 2021-2026
o Exhibit 32: Chart on Sprue - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Sprue - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Sprue - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Sprue - Year-over-year growth 2021-2026 (%)
o 5.5 Cystic fibrosis - Market size and forecast 2021-2026
o Exhibit 36: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Disease Type
o Exhibit 40: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Koninklijke DSM NV
o Exhibit 92: Koninklijke DSM NV - Overview
o Exhibit 93: Koninklijke DSM NV - Business segments
o Exhibit 94: Koninklijke DSM NV - Key news
o Exhibit 95: Koninklijke DSM NV - Key offerings
o Exhibit 96: Koninklijke DSM NV - Segment focus
o 10.5 Lannett Co. Inc.
o Exhibit 97: Lannett Co. Inc. - Overview
o Exhibit 98: Lannett Co. Inc. - Product / Service
o Exhibit 99: Lannett Co. Inc. - Key news
o Exhibit 100: Lannett Co. Inc. - Key offerings
o 10.6 Merck and Co. Inc.
o Exhibit 101: Merck and Co. Inc. - Overview
o Exhibit 102: Merck and Co. Inc. - Business segments
o Exhibit 103: Merck and Co. Inc. - Key news
o Exhibit 104: Merck and Co. Inc. - Key offerings
o Exhibit 105: Merck and Co. Inc. - Segment focus
o 10.7 Novartis AG
o Exhibit 106: Novartis AG - Overview
o Exhibit 107: Novartis AG - Business segments
o Exhibit 108: Novartis AG - Key offerings
o Exhibit 109: Novartis AG - Segment focus
o 10.8 Organon and Co.
o Exhibit 110: Organon and Co. - Overview
o Exhibit 111: Organon and Co. - Product / Service
o Exhibit 112: Organon and Co. - Key offerings
o 10.9 Perrigo Co. Plc
o Exhibit 113: Perrigo Co. Plc - Overview
o Exhibit 114: Perrigo Co. Plc - Business segments
o Exhibit 115: Perrigo Co. Plc - Key offerings
o Exhibit 116: Perrigo Co. Plc - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 117: Pfizer Inc. - Overview
o Exhibit 118: Pfizer Inc. - Product / Service
o Exhibit 119: Pfizer Inc. - Key news
o Exhibit 120: Pfizer Inc. - Key offerings
o 10.11 ProThera Biologics Inc.
o Exhibit 121: ProThera Biologics Inc. - Overview
o Exhibit 122: ProThera Biologics Inc. - Product / Service
o Exhibit 123: ProThera Biologics Inc. - Key offerings
o 10.12 Sanofi
o Exhibit 124: Sanofi - Overview
o Exhibit 125: Sanofi - Business segments
o Exhibit 126: Sanofi - Key news
o Exhibit 127: Sanofi - Key offerings
o Exhibit 128: Sanofi - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 129: Inclusions checklist
o Exhibit 130: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 131: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 132: Research methodology
o Exhibit 133: Validation techniques employed for market sizing
o Exhibit 134: Information sources
o 11.5 List of abbreviations
o Exhibit 135: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Lactose intolerance - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Lactose intolerance - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Lactose intolerance - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Sprue - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Sprue - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Sprue - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Sprue - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Disease Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Koninklijke DSM NV - Overview
Exhibits93: Koninklijke DSM NV - Business segments
Exhibits94: Koninklijke DSM NV - Key news
Exhibits95: Koninklijke DSM NV - Key offerings
Exhibits96: Koninklijke DSM NV - Segment focus
Exhibits97: Lannett Co. Inc. - Overview
Exhibits98: Lannett Co. Inc. - Product / Service
Exhibits99: Lannett Co. Inc. - Key news
Exhibits100: Lannett Co. Inc. - Key offerings
Exhibits101: Merck and Co. Inc. - Overview
Exhibits102: Merck and Co. Inc. - Business segments
Exhibits103: Merck and Co. Inc. - Key news
Exhibits104: Merck and Co. Inc. - Key offerings
Exhibits105: Merck and Co. Inc. - Segment focus
Exhibits106: Novartis AG - Overview
Exhibits107: Novartis AG - Business segments
Exhibits108: Novartis AG - Key offerings
Exhibits109: Novartis AG - Segment focus
Exhibits110: Organon and Co. - Overview
Exhibits111: Organon and Co. - Product / Service
Exhibits112: Organon and Co. - Key offerings
Exhibits113: Perrigo Co. Plc - Overview
Exhibits114: Perrigo Co. Plc - Business segments
Exhibits115: Perrigo Co. Plc - Key offerings
Exhibits116: Perrigo Co. Plc - Segment focus
Exhibits117: Pfizer Inc. - Overview
Exhibits118: Pfizer Inc. - Product / Service
Exhibits119: Pfizer Inc. - Key news
Exhibits120: Pfizer Inc. - Key offerings
Exhibits121: ProThera Biologics Inc. - Overview
Exhibits122: ProThera Biologics Inc. - Product / Service
Exhibits123: ProThera Biologics Inc. - Key offerings
Exhibits124: Sanofi - Overview
Exhibits125: Sanofi - Business segments
Exhibits126: Sanofi - Key news
Exhibits127: Sanofi - Key offerings
Exhibits128: Sanofi - Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Validation techniques employed for market sizing
Exhibits134: Information sources
Exhibits135: List of abbreviations